By Sheri Kasprzak
New York, June 27 - ISTA Pharmaceuticals, Inc. is gearing up to wrap a $36.75 million private placement of stock.
A group of institutional investors agreed to buy 5.25 million shares at $7.00 apiece.
The deal is expected to close on June 29.
Lehman Brothers is the lead agent with Lazard Freres & Co. LLC, Susquehanna Financial Group, LLLP and Thomas Weisel Partners LLC as co-agents.
Located in Irvine, Calif., ISTA is a pharmaceutical company focused on developing treatments for conditions like dry eye, vitreous hemorrhage, diabetic retinopathy, glaucoma and ocular pain.
| Issuer: | ISTA Pharmaceuticals, Inc.
|
| Issue: | Stock
|
| Amount: | $36.75 million
|
| Shares: | 5.25 million
|
| Price: | $7.00
|
| Warrants: | No
|
| Placement agents: | Lehman Brothers (lead); Lazard Freres & Co. LLC; Susquehanna Financial Group, LLLP; Thomas Weisel Partners LLC
|
| Announcement date: | June 27
|
| Settlement date: | June 29
|
| Stock symbol: | Nasdaq: ISTA
|
| Stock price: | $7.32 at close June 26
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
